Revolution Medicines, Inc. Change in Other Liabilities increased by 242.8% to $5.66M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 63.3%, from $3.47M to $5.66M.
An increase suggests the company is deferring obligations or increasing long-term liabilities, providing a source of cash.
Captures the net change in non-current or miscellaneous liabilities not classified as debt or standard accounts payable....
Commonly used to track non-operating liability fluctuations across industrial peers.
change_in_other_liabilities| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$797.00K | $366.00K | $1.03M | -$1.39M | $340.00K | -$170.00K | $1.39M | -$1.44M | $730.00K | $2.13M | -$2.23M | $1.08M | $3.47M | $2.31M | -$3.97M | $5.66M |
| QoQ Change | — | +145.9% | +181.7% | -234.9% | +124.4% | -150.0% | +919.4% | -203.5% | +150.6% | +192.1% | -204.5% | +148.3% | +222.6% | -33.5% | -272.1% | +242.8% |
| YoY Change | — | — | — | -74.5% | -7.1% | — | +35.1% | -3.7% | +114.7% | +53.1% | -54.4% | +47.3% | +62.7% | +203.5% | -468.9% | +63.3% |